MCVAX | MVCAX | MCVAX / MVCAX | |
Total Expense Ratio | 1.19 | 0.99 | 120% |
Annual Report Gross Expense Ratio | 1.19 | 1.00 | 119% |
Fund Existence | 11 years | 24 years | - |
Gain YTD | 0.284 | -4.042 | -7% |
Front Load | 6% | 6% | 96% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 968M | 16.5B | 6% |
Annual Yield % from dividends | 1.11 | 0.93 | 119% |
Returns for 1 year | -5.08 | -8.01 | 63% |
Returns for 3 years | -7.41 | 4.54 | -163% |
Returns for 5 years | 29.15 | 71.01 | 41% |
Returns for 10 years | -3.10 | 49.80 | -6% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TARK | 34.74 | 3.65 | +11.74% |
Tradr 2X Long Innovation ETF | |||
DFLV | 30.32 | 0.78 | +2.64% |
Dimensional US Large Cap Value ETF | |||
PMAR | 40.87 | 0.72 | +1.79% |
Innovator U.S. Equity Power BffrETF™-Mar | |||
HCOM | 15.51 | N/A | N/A |
Hartford Schroders Commodity Strtgy ETF | |||
DMB | 10.25 | -0.07 | -0.68% |
BNY Mellon Municipal |